genetics

Home/Tag: genetics

Gene editing technology may improve accuracy of predicting individuals’ heart disease risk

Scientists may now be able to predict whether carrying a specific genetic variant increases a person's risk for disease using gene editing and stem cell technologies, according to new research in the American Heart Association's journal Circulation. For the first time, the study demonstrates the unique potential of combining stem cell-based disease modeling (Induced pluripotent stem

June 21st, 2018|Categories: General News|Tags: , , |

$7 million aimed at illuminating the genetics of Alzheimer’s disease

Researchers working to identify genetic factors that raise, lower disease risk by Tamara Bhandari•March 13, 2017 OSCAR HARARI Studies are underway to identify the genetic networks that affect a person's risk of developing Alzheimer's disease. The researchers are aiming to find ways to predict who will develop the neurodegenerative disease, at what age and how

Biogen, ALS Association, and Columbia University Med Center to Explore ALS Genetics

Source: © iceteastock/Fotolia.com Aug. 18, 2015 - Biogen, the ALS Association, and Columbia UniversityMedical Center (CUMC) agreed to collaborate to better understand the differences and commonalities in the ALS disease process and how genes influence the clinical features of the disease. The project, “Genomic Translation for ALS Clinical care” (GTAC), will involve a combination of next-generation

Scientists Develop Free, Online Genetic Research Tool

RNAMiner makes genetic science easier, could lead to faster results July 07, 2015 by Jeff Sossamon Jianlin Cheng, Jilong Li and Jie Hou recently developed RNAMiner, a website making it easier for scientists to analyze genomic data. Credit: Ryan Owens, MU College of Engineering COLUMBIA, Mo. – Technology rapidly is advancing the study of genetics and

23andMe’s Plan to Harness Data for Disease Treatments

Thu, 05/28/2015 - 8:59am Ryan Bushey, Associate Editor Dr. Robert Gentleman. Source: 23andMeEarlier this year, 23andMe announced it would be starting a new business.The nearly 10-year-old biotechnology company headquartered in Mountain View, California formed a new therapeutics division, which would be responsible for using 23andMe’s large database of genetic information to discover and develop drugs for

Study shows who benefits most from statins

March 3, 2015 By Julia Evangelou Strait ROBERT BOSTON Nathan O. Stitziel, MD, PhD, a Washington University cardiologist and human geneticist, is co-first author on a study that suggests that widely used statin therapy provides the most benefit to patients with the highest genetic risk of heart attack. New research suggests that widely used statin

Tiny fish makes big splash in aging research at Stanford

 Feb 12, 2015 by Krista Conger Researchers disabled aging-associated genes in the short-lived African killifish, including one for an enzyme called telomerase, whose absence caused humanlike disease in the animal. Anne Brunet and her colleagues have found that the short-lived African killifish is a useful model for studying the aging process. Gregg Segal “Live fast,

Uncovering Clues to the Genetic Cause of Schizophrenia

Bioscience Technology, Source: Columbia University Medical Center ~ May 29, 2014 The overall number and nature of mutations—rather than the presence of any single mutation—influences an individual’s risk of developing schizophrenia, as well as its severity, according to a study by Columbia University Medical Center researchers published in the latest issue of Neuron. The findings

Researchers Discover Underlying Genetics Tied To Increased Risk For Stroke And Cardiovascular Disease

Red Orbit, by Staff ~ March 21, 2014 NIH-funded findings point to new potential strategies for disease prevention, treatment Scientists studying the genomes of nearly 5,000 people have pinpointed a genetic variant tied to an increased risk for stroke, and have also uncovered new details about an important metabolic pathway that plays a major role

Arthritis Genetics Analysis Aids Drug Discovery

National Institutes of Health, by Carol Torgan, Ph.D. ~ January 13, 2014 An international research team identified 42 new areas in the human genome associated with rheumatoid arthritis—and found that many are already the targets of drugs approved for other conditions. The findings hint at new treatment approaches for the disease. DNA helixes in pill

January 15th, 2014|Categories: General News|Tags: , , |